Harmony Biosciences Holdings, Inc. (HRMY)
42.90
+1.64
(+3.99%)
USD |
NASDAQ |
Sep 02, 16:00
42.90
0.00 (0.00%)
After-Hours: 17:53
Harmony Biosciences Holdings Research and Development Expense (TTM) : 220.87M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 220.87M |
| March 31, 2026 | 224.44M |
| December 31, 2025 | 189.59M |
| September 30, 2025 | 174.33M |
| June 30, 2025 | 144.75M |
| March 31, 2025 | 158.18M |
| December 31, 2024 | 145.82M |
| September 30, 2024 | 141.46M |
| June 30, 2024 | 133.58M |
| March 31, 2024 | 84.96M |
| December 31, 2023 | 76.06M |
| September 30, 2023 | 55.85M |
| June 30, 2023 | 78.90M |
| March 31, 2023 | 76.60M |
| Date | Value |
|---|---|
| December 31, 2022 | 70.89M |
| September 30, 2022 | 68.24M |
| June 30, 2022 | 39.44M |
| March 31, 2022 | 33.27M |
| December 31, 2021 | 30.37M |
| September 30, 2021 | 30.54M |
| June 30, 2021 | 23.03M |
| March 31, 2021 | 20.70M |
| December 31, 2020 | 19.45M |
| September 30, 2020 | 19.11M |
| June 30, 2020 | 19.21M |
| March 31, 2020 | 20.04M |
| December 31, 2019 | 69.60M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Liquidia Corp. | 54.95M |
| Repligen Corp. | 55.23M |
| Johnson & Johnson | 15.06B |
| ACADIA Pharmaceuticals, Inc. | 331.01M |
| ANI Pharmaceuticals, Inc. | 49.91M |